Format

Send to

Choose Destination
See comment in PubMed Commons below
Epilepsy Behav. 2006 May;8(3):588-92. Epub 2006 Feb 13.

The impact of levetiracetam on challenging behavior.

Author information

  • 1Psychology Department, National Society for Epilepsy, Chalfont St. Peter, Bucks, UK. barbara.hurtado@epilepsynse.org.uk

Abstract

An observational longitudinal design was employed to evaluate whether treatment with the antiepileptic drug levetiracetam (LEV) adversely impacts behavior in people with intellectual disabilities and/or acquired brain damage. Thirty-five adults were assessed once off the drug and once when on LEV therapy, with a 2-month interval between assessments. Behaviors were rated using an adaptation of the Yale-Brown Obsessive Compulsive Scale and the Challenging Behaviour Scale. Challenging behaviors were rated as more frequent and severe when individuals were taking LEV. Behavioral worsening was not related to better seizure control or increased levels of engagement in activities. Families and professionals need to be aware of the potential reversible adverse effects of this drug.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk